Calcium channel blockers: molecular docking and inhibition studies on carbonic anhydrase I and II isoenzymes

References

• Akbaba, Y., Türkeş, C., Polat, L., Söyüt, H., Şahin, E., Menzek, A., Göksu, S., & Beydemir, Ş. (2013). Synthesis and paroxonase activities of novel bromophenols. Journal of Enzyme Inhibition and Medicinal Chemistry, 28(5), 1073–1079. doi:10.3109/14756366.2012.715287
   PubMed Web of Science ®Google Scholar
• Alım, Z., Kılınç, N., İşgör, M. M., Şengül, B., & Beydemir, Ş. (2015). Some anti‐inflammatory agents inhibit esterase activities of human carbonic anhydrase isoforms I and II: An in vitro study. Chemical Biology & Drug Design, 86(4), 857–863. doi:10.1111/cbdd.12561
   PubMed Web of Science ®Google Scholar
• Anekonda, T. S., Quinn, J. F., Harris, C., Frahler, K., Wadsworth, T. L., & Woltjer, R. L. (2011). L-type voltage-gated calcium channel blockade with isradipine as a therapeutic strategy for Alzheimer’s disease. Neurobiology of Disease, 41(1), 62–70. doi:10.1016/j.nbd.2010.08.020
   PubMed Web of Science ®Google Scholar
• Ansari, M. A., Iqubal, A., Ekbbal, R., & Haque, S. E. (2019). Effects of nimodipine, vinpocetine and their combination on isoproterenol-induced myocardial infarction in rats. Biomedicine & Pharmacotherapy, 109, 1372–1380. doi:10.1016/j.biopha.2018.10.199
   PubMed Web of Science ®Google Scholar
• Aslan, H. E., Demir, Y., Özaslan, M. S., Türkan, F., Beydemir, Ş., & Küfrevioğlu, Ö. I. (2019). The behavior of some chalcones on acetylcholinesterase and carbonic anhydrase activity. Drug and Chemical Toxicology, 42(6), 634–640. doi:10.1080/01480545.2018.1463242
   PubMed Web of Science ®Google Scholar
• Bal, S., Kaya, R., Gök, Y., Taslimi, P., Aktaş, A., Karaman, M., & Gülçin, İ. (2020). Novel 2-methylimidazolium salts: Synthesis, characterization, molecular docking, and carbonic anhydrase and acetylcholinesterase inhibitory properties. Bioorganic Chemistry, 94, 103468. doi:10.1016/j.bioorg.2019.103468
   PubMed Web of Science ®Google Scholar
• Batlle, D. C., Saleh, A., & Rombola, G. (1990). Reduced intracellular pH in lymphocytes from the spontaneously hypertensive rat. Hypertension, 15(1), 97–103. doi:10.1161/01.HYP.15.1.97
   PubMed Web of Science ®Google Scholar
• Bayindir, S., Caglayan, C., Karaman, M., & Gülcin, İ. (2019). The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes. Bioorganic Chemistry, 90, 103096. doi:10.1016/j.bioorg.2019.103096
   PubMed Web of Science ®Google Scholar
• Bayrak, Ç., Taslimi, P., Gülçin, İ., & Menzek, A. (2017). The first synthesis of 4-phenylbutenone derivative bromophenols including natural products and their inhibition profiles for carbonic anhydrase, acetylcholinesterase and butyrylcholinesterase enzymes. Bioorganic Chemistry, 72, 359–366. doi:10.1016/j.bioorg.2017.03.001
   PubMed Web of Science ®Google Scholar
• Beydemir, Ş., Çİftçi, M., Özmen, İ., Okuroglu, M. E. B., Özdemir, H., & Küfrevioglu, öİ. (2000). Effects of some medical drugs on enzyme activities of carbonic anhydrase from human erythrocytes in vitro and from rat erythrocytes in vivo. Pharmacological Research, 42(2), 187–191. doi:10.1006/phrs.2000.0674
   PubMed Web of Science ®Google Scholar
• Beydemir, Ş., Türkeş, C., & Yalçın, A. (2019). Gadolinium-based contrast agents: In vitro paraoxonase 1 inhibition, in silico studies. Drug and Chemical Toxicology, 1–10. doi:10.1080/01480545.2019.1620266
   PubMed Web of Science ®Google Scholar
• Biçer, A., Taslimi, P., Yakalı, G., Gülçin, I., Gültekin, M. S., & Cin, G. T. (2019). Synthesis, characterization, crystal structure of novel bis-thiomethylcyclohexanone derivatives and their inhibitory properties against some metabolic enzymes. Bioorganic Chemistry, 82, 393–404. doi:10.1016/j.bioorg.2018.11.001
   PubMed Web of Science ®Google Scholar
• Bilginer, S., Gonder, B., Gul, H. I., Kaya, R., Gulcin, I., Anil, B., & Supuran, C. T. (2020). Novel sulphonamides incorporating triazene moieties show powerful carbonic anhydrase I and II inhibitory properties. Journal of Enzyme Inhibition and Medicinal Chemistry, 35(1), 325–329. doi:10.1080/14756366.2019.1700240
   PubMed Web of Science ®Google Scholar
• Boztas, M., Taslimi, P., Yavari, M. A., Gulcin, I., Sahin, E., & Menzek, A. (2019). Synthesis and biological evaluation of bromophenol derivatives with cyclopropyl moiety: Ring opening of cyclopropane with monoester. Bioorganic Chemistry, 89, 103017. doi:10.1016/j.bioorg.2019.103017
   PubMed Web of Science ®Google Scholar
• Bradford, M. M. (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry, 72(1–2), 248–254. doi:10.1016/0003-2697(76)90527-3
   PubMed Web of Science ®Google Scholar
• Brechue, W. F., Stager, J. M., & Lukaski, H. C. (1990). Body water and electrolyte responses to acetazolamide in humans. Journal of Applied Physiology, 69(4), 1397–1401. doi:10.1152/jappl.1990.69.4.1397
   PubMed Web of Science ®Google Scholar
• Burmaoglu, S., Yilmaz, A. O., Polat, M. F., Kaya, R., Gulcin, İ., & Algul, O. (2019). Synthesis of novel tris-chalcones and determination of their inhibition profiles against some metabolic enzymes. Archives of Physiology and Biochemistry, 1–9. doi:10.1080/13813455.2019.1623265
   PubMed Web of Science ®Google Scholar
• Bytyqi-Damoni, A., Kestane, A., Taslimi, P., Tuzun, B., Zengin, M., Bilgicli, H. G., & Gulcin, İ. (2020). Novel carvacrol based new oxypropanolamine derivatives: Design, synthesis, characterization, biological evaluation, and molecular docking studies. Journal of Molecular Structure, 1202, 127297. doi:10.1016/j.molstruc.2019.127297
   Web of Science ®Google Scholar
• Çağlayan, C., Taslimi, P., Demir, Y., Küçükler, S., Kandemir, F. M., & Gulçin, İ. (2019). The effects of zingerone against vancomycin‐induced lung, liver, kidney and testis toxicity in rats: The behavior of some metabolic enzymes. Journal of Biochemical and Molecular Toxicology, 33(10), e22381. doi:10.1002/jbt.22381
   PubMed Web of Science ®Google Scholar
• Caglayan, C., Demir, Y., Kucukler, S., Taslimi, P., Kandemir, F. M., & Gulçin, İ. (2019). The effects of hesperidin on sodium arsenite‐induced different organ toxicity in rats on metabolic enzymes as antidiabetic and anticholinergics potentials: A biochemical approach. Journal of Food Biochemistry, 43(2), e12720. doi:10.1111/jfbc.12720
   PubMed Web of Science ®Google Scholar
• Caglayan, C., Taslimi, P., Türk, C., Kandemir, F. M., Demir, Y., & Gulcin, İ. (2019). Purification and characterization of the carbonic anhydrase enzyme from horse mackerel (Trachurus trachurus) muscle and the impact of some metal ions and pesticides on enzyme activity. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 226, 108605. doi:10.1016/j.cbpc.2019.108605
   PubMed Web of Science ®Google Scholar
• Cakmak, K. C., & Gülçin, İ. (2019). Anticholinergic and antioxidant activities of usnic acid-an activity-structure insight. Toxicology Reports, 6, 1273–1280. doi:10.1016/j.toxrep.2019.11.003
   PubMed Web of Science ®Google Scholar
• Ceylan, H., Demir, Y., & Beydemir, Ş. (2019). Inhibitory effects of usnic and carnosic acid on some metabolic enzymes: An in vitro study. Protein & Peptide Letters, 26(5), 364–370. doi:10.2174/0929866526666190301115122
   PubMed Web of Science ®Google Scholar
• Coban, T. A., Beydemir, Ş., Gücin, İ., Ekinci, D., Innocenti, A., Vullo, D., & Supuran, C. T. (2009). Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I–XIV. Bioorganic & Medicinal Chemistry, 17(16), 5791–5795. doi:10.1016/j.bmc.2009.07.019
   PubMed Web of Science ®Google Scholar
• Demir, Y. (2019). The behaviour of some antihypertension drugs on human serum paraoxonase‐1: An important protector enzyme against atherosclerosis. Journal of Pharmacy and Pharmacology, 71(10), 1576–1583. doi:10.1111/jphp.13144
   PubMed Web of Science ®Google Scholar
• Demir, Y., & Beydemir, Ş. (2015). Purification, refolding, and characterization of recombinant human paraoxonase-1. Turkish Journal of Chemistry, 39(4), 764–776. doi:10.3906/kim-1501-51
   Web of Science ®Google Scholar
• Demir, Y., & Köksal, Z. (2019). The inhibition effects of some sulfonamides on human serum paraoxonase-1 (hPON1). Pharmacological Reports, 71(3), 545–549. doi:10.1016/j.pharep.2019.02.012
   PubMed Web of Science ®Google Scholar
• Demir, Y., Duran, H. E., Durmaz, L., Taslimi, P., Beydemir, Ş., & Gulçin, İ. (2020). The influence of some nonsteroidal anti-inflammatory drugs on metabolic enzymes of aldose reductase, sorbitol dehydrogenase, and α-glycosidase: A perspective for metabolic disorders. Applied Biochemistry and Biotechnology, 190(2), 437–447. doi:10.1007/s12010-019-03099-7
   PubMed Web of Science ®Google Scholar
• Demir, Y., Türkeş, C., & Beydemir, Ş. (2020). Molecular docking studies and inhibition properties of some antineoplastic agents against paraoxonase-I. Anti-Cancer Agents in Medicinal Chemistry, 20. doi:10.2174/1871520620666200218110645
   PubMed Web of Science ®Google Scholar
• Ekinci, D., Beydemir, S., & Alim, Z. (2007). Some drugs inhibit in vitro hydratase and esterase activities of human carbonic anhydrase-I and II. Pharmacological Reports, 59(5), 580–587####587.
   PubMed Web of Science ®Google Scholar
• Ellory, J. C., Kirk, K., Culliford, S. J., Nash, G. B., & Stuart, J. (1992). Nitrendipine is a potent inhibitor of the Ca2+‐activated K + channel of human erythrocytes. FEBS Letters, 296(2), 219–221. doi:10.1016/0014-5793(92)80383-R
   PubMed Web of Science ®Google Scholar
• Erdemir, F., Celepci, D. B., Aktaş, A., Gök, Y., Kaya, R., Taslimi, P., Demir, Y., & Gulçin, İ. (2019). Novel 2-aminopyridine liganded Pd (II) N-heterocyclic carbene complexes: Synthesis, characterization, crystal structure and bioactivity properties. Bioorganic Chemistry, 91, 103134. doi:10.1016/j.bioorg.2019.103134
   PubMed Web of Science ®Google Scholar
• Friesner, R. A., Banks, J. L., Murphy, R. B., Halgren, T. A., Klicic, J. J., Mainz, D. T., Repasky, M. P., Knoll, E. H., Shelley, M., Perry, J. K., Shaw, D. E., Francis, P., & Shenkin, P. S. (2004). Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. Journal of Medicinal Chemistry, 47(7), 1739–1749. doi:10.1007/s11356-020-07611-z
   PubMed Web of Science ®Google Scholar
• Garibov, E., Taslimi, P., Sujayev, A., Bingol, Z., Çetinkaya, S., Gulçin, İ., Beydemir, S., Farzaliyev, V., Alwasel, S. H., & Supuran, C. T. (2016). Synthesis of 4, 5-disubstituted-2-thioxo-1, 2, 3, 4-tetrahydropyrimidines and investigation of their acetylcholinesterase, butyrylcholinesterase, carbonic anhydrase I/II inhibitory and antioxidant activities. Journal of Enzyme Inhibition and Medicinal Chemistry, 31(sup3), 1–9. doi:10.1080/14756366.2016.1198901
   PubMed Web of Science ®Google Scholar
• Godfraind, T. (2017). Discovery and development of calcium channel blockers. Frontiers in Pharmacology, 8, 286. doi:10.3389/fphar.2017.00286
   PubMed Web of Science ®Google Scholar
• Gul, H. I., Mete, E., Taslimi, P., Gulcin, I., & Supuran, C. T. (2017). Synthesis, carbonic anhydrase I and II inhibition studies of the 1, 3, 5-trisubstituted-pyrazolines. Journal of Enzyme Inhibition and Medicinal Chemistry, 32(1), 189–192. doi:10.1080/14756366.2016.1244533
   PubMed Web of Science ®Google Scholar
• Gulçin, İ., & Taslimi, P. (2018). Sulfonamide inhibitors: A patent review 2013-present. Expert Opinion on Therapeutic Patents, 28(7), 541–549. doi:10.1080/13543776.2018.1487400
   PubMed Web of Science ®Google Scholar
• Gülçin, İ., Beydemir, Ş., & Büyükokuroğlu, M. E. (2004). In vitro and in vivo effects of dantrolene on carbonic anhydrase enzyme activities. Biological & Pharmaceutical Bulletin, 27(5), 613–616. doi:10.1248/bpb.27.613
   PubMed Web of Science ®Google Scholar
• Gülçin, I., Beydemir, Ş., Çoban, T. A., & Ekinci, D. (2008). The inhibitory effect of dantrolene sodium and propofol on 6-phosphogluconate dehydrogenase from rat erythrocyte. Fresen Environ Bull, 17(9A), 1283–1287.
   Web of Science ®Google Scholar
• Gündoğdu, S., Türkeş, C., Arslan, M., Demir, Y., & Beydemir, Ş. (2019). New isoindole‐1, 3‐dione substituted sulfonamides as potent inhibitors of carbonic anhydrase and acetylcholinesterase: design, synthesis, and biological evaluation. ChemistrySelect, 4(45), 13347–13355. doi:10.1002/slct.201903458
   Web of Science ®Google Scholar
• Halgren, T. A., Murphy, R. B., Friesner, R. A., Beard, H. S., Frye, L. L., Pollard, W. T., & Banks, J. L. (2004). Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. Journal of Medicinal Chemistry, 47(7), 1750–1759. doi:10.1021/jm030644s
   PubMed Web of Science ®Google Scholar
• Harder, E., Damm, W., Maple, J., Wu, C., Reboul, M., Xiang, J. Y., Wang, L., Lupyan, D., Dahlgren, M. K., Knight, J. L., Kaus, J. W., Cerutti, D. S., Krilov, G., Jorgensen, W. L., Abel, R., & Friesner, R. A. (2016). OPLS3: A force field providing broad coverage of drug-like small molecules and proteins. Journal of Chemical Theory and Computation, 12(1), 281–296. doi:10.1021/acs.jctc.5b00864
   PubMed Web of Science ®Google Scholar
• Işık, M., Beydemir, Ş., Demir, Y., Durgun, M., Türkeş, C., Nasır, A., Necip, A., & Akkuş, M. (2020). Benzenesulfonamide derivatives containing imine and amine groups: Inhibition on human paraoxonase and molecular docking studies. International Journal of Biological Macromolecules, 146, 1111–1123. doi:10.1016/j.ijbiomac.2019.09.237
   PubMed Web of Science ®Google Scholar
• Işık, M., Demir, Y., Durgun, M., Türkeş, C., Necip, A., & Beydemir, Ş. (2019). Molecular docking and investigation of 4-(benzylideneamino)-and 4-(benzylamino)-benzenesulfonamide derivatives as potent AChE inhibitors. Chemical Papers, 1–11. doi:10.1007/s11696-019-00988-3
   Web of Science ®Google Scholar
• John, A., Sivashanmugam, M., Natarajan, S. K., & Umashankar, V. (2019). Computational modeling of novel inhibitory peptides targeting proteoglycan like region of carbonic anhydrase IX and in vitro validation in HeLa cells. Journal of Biomolecular Structure and Dynamics, 1–12. doi:10.1080/07391102.2019.1623075
   PubMed Web of Science ®Google Scholar
• Kumar, A., Rathi, E., & Kini, S. G. (2019). Identification of potential tumour-associated carbonic anhydrase isozyme IX inhibitors: Atom-based 3D-QSAR modelling, pharmacophore-based virtual screening and molecular docking studies. Journal of Biomolecular Structure and Dynamics, 1–15. doi:10.1080/07391102.2019.1626285
   Web of Science ®Google Scholar
• Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227(5259), 680–685. doi:10.1038/227680a0
   PubMed Web of Science ®Google Scholar
• Lawlor, B., Segurado, R., Kennelly, S., Rikkert, M. G. M. O., Howard, R., Pasquier, F., … Molloy, D. W. (2018). Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial. PLoS Medicine, (9), 15. doi:10.1371/journal.pmed.1002660
   Web of Science ®Google Scholar
• Lineweaver, H., & Burk, D. (1934). The determination of enzyme dissociation constants. Journal of the American Chemical Society, 56(3), 658–666. doi:10.1021/ja01318a036
   Google Scholar
• Ničković, V. P., Mitić, N. R., Krdžić, B. D., Krdžić, J. D., Nikolić, G. R., Vasić, M. Z., Ranković, G., Babović, P., Sokolović, D., & Veselinović, A. M. (2019). Design and development of novel therapeutics for brucellosis treatment based on carbonic anhydrase inhibition. Journal of Biomolecular Structure and Dynamics, 1–10. doi:10.1080/07391102.2019.1619626
   PubMed Web of Science ®Google Scholar
• Puscas, I., Coltau, M., Domuta, G., Baican, M., Puscas, C., & Pasca, R. (2000). Carbonic anhydrase I inhibition by nitric oxide: Implications for mediation of the hypercapnia‐induced vasodilator response. Clinical and Experimental Pharmacology and Physiology, 27(1–2), 95–99. doi:10.1046/j.1440-1681.2000.03212.x
   PubMed Web of Science ®Google Scholar
• Puscas, I., Gilau, L., Coltau, M., Pasca, R., Domuta, G., Baican, M., & Hecht, A. (2000). Calcium channel blockers reduce blood pressure in part by inhibiting vascular smooth muscle carbonic anhydrase I. Cardiovascular Drugs and Therapy, 14(5), 523–528.
   PubMed Web of Science ®Google Scholar
• Redon, J., & Batlle, D. (1994). Regulation of intracellular pH in the spontaneously hypertensive rat. Role of bicarbonate-dependent transporters. Hypertension, 23(4), 503–512. doi:10.1161/01.HYP.23.4.503
   PubMed Web of Science ®Google Scholar
• Resnick, L. M., Gupta, R. K., DiFabio, B., Barbagallo, M., Mann, S., Marion, R., & Laragh, J. H. (1994). Intracellular ionic consequences of dietary salt loading in essential hypertension. Relation to blood pressure and effects of calcium channel blockade. Journal of Clinical Investigation, 94(3), 1269–1276. doi:10.1172/JCI117445
   PubMed Web of Science ®Google Scholar
• Sağlık, B. N., Çevik, U. A., Osmaniye, D., Levent, S., Çavuşoğlu, B. K., Demir, Y., Ilgın, S., Özkay, Y., Koparal, A. S., Beydemir, Ş., & Kaplancıklı, Z. A. (2019). Synthesis, molecular docking analysis and carbonic anhydrase I-II inhibitory evaluation of new sulfonamide derivatives. Bioorganic Chemistry, 91, 103153. doi:10.1016/j.bioorg.2019.103153
   PubMed Web of Science ®Google Scholar
• Saleh, A. M., & Batlle, D. C. (1990). Kinetic properties of the Na+/H + antiporter of lymphocytes from the spontaneously hypertensive rat: Role of intracellular pH. Journal of Clinical Investigation, 85(6), 1734–1739. doi:10.1172/JCI114629
   PubMed Web of Science ®Google Scholar
• Şen, E., Alım, Z., Duran, H., İşgör, M. M., Beydemir, Ş., Kasımoğulları, R., & Ok, S. (2013). Inhibitory effect of novel pyrazole carboxamide derivatives on human carbonic anhydrase enzyme. Journal of Enzyme Inhibition and Medicinal Chemistry, 28(2), 328–336. doi:10.3109/14756366.2011.651465
   PubMed Web of Science ®Google Scholar
• Şentürk, M., Gülçin, İ., Ciftci, M., & Küfrevioğlu, Ö. İ. (2008). Dantrolene inhibits human erythrocyte glutathione reductase. Biological & Pharmaceutical Bulletin, 31(11), 2036–2039. doi:10.1248/bpb.31.2036
   PubMed Web of Science ®Google Scholar
• Shaik, N. A., Bokhari, H. A., Masoodi, T. A., Shetty, P. J., Ajabnoor, G. M. A., Elango, R., & Banaganapalli, B. (2019). Molecular modelling and dynamics of CA2 missense mutations causative to carbonic anhydrase 2 deficiency syndrome. Journal of Biomolecular Structure and Dynamics, 1–14. doi:10.1080/07391102.2019.1671899
   PubMedGoogle Scholar
• Shringirishi, M., Mahor, A., Gupta, R., Prajapati, S. K., Bansal, K., & Kesharwani, P. (2017). Fabrication and characterization of nifedipine loaded β-cyclodextrin nanosponges: An in vitro and in vivo evaluation. Journal of Drug Delivery Science and Technology, 41, 344–350. doi:10.1016/j.jddst.2017.08.005
   Web of Science ®Google Scholar
• Taslimi, P., Aslan, H. E., Demir, Y., Oztaskin, N., Maraş, A., Gulçin, İ., Beydemir, S., & Goksu, S. (2018). Diarylmethanon, bromophenol and diarylmethane compounds: Discovery of potent aldose reductase, α-amylase and α-glycosidase inhibitors as new therapeutic approach in diabetes and functional hyperglycemia. International Journal of Biological Macromolecules, 119, 857–863. doi:10.1016/j.ijbiomac.2018.08.004
   PubMed Web of Science ®Google Scholar
• Taslimi, P., Kandemir, F. M., Demir, Y., İleritürk, M., Temel, Y., Caglayan, C., & Gulçin, İ. (2019). The antidiabetic and anticholinergic effects of chrysin on cyclophosphamide‐induced multiple organ toxicity in rats: Pharmacological evaluation of some metabolic enzyme activities. Journal of Biochemical and Molecular Toxicology, 33(6), e22313. doi:10.1002/jbt.22313
   PubMed Web of Science ®Google Scholar
• Topal, A., Atamanalp, M., Oruç, E., Demir, Y., Beydemir, Ş., & Işık, A. (2014). In vivo changes in carbonic anhydrase activity and histopathology of gill and liver tissues after acute exposure to chlorpyrifos in rainbow trout. Archives of Industrial Hygiene and Toxicology, 65(4), 377–385. doi:10.2478/10004-1254-65-2014-2547
   PubMed Web of Science ®Google Scholar
• Triggle, D. J. (2007). Calcium channel antagonists: Clinical uses—past, present and future. Biochemical Pharmacology, 74(1), 1–9. doi:10.1016/j.bcp.2007.01.016
   PubMed Web of Science ®Google Scholar
• Türkan, F., Huyut, Z., Demir, Y., Ertaş, F., & Beydemir, Ş. (2019). The effects of some cephalosporins on acetylcholinesterase and glutathione S-transferase: An in vivo and in vitro study. Archives of Physiology and Biochemistry, 125(3), 235–243. doi:10.1080/13813455.2018.1452037
   PubMed Web of Science ®Google Scholar
• Türkeş, C. (2019a). Inhibition effects of phenolic compounds on human serum paraoxonase-1 enzyme. Journal of the Institute of Science and Technology, 9(2), 1013–1022. doi:10.21597/jist.491054
   Google Scholar
• Türkeş, C. (2019b). Investigation of potential paraoxonase-I inhibitors by kinetic and molecular docking studies: Chemotherapeutic drugs. Protein & Peptide Letters, 26(6), 392–402. doi:10.2174/0929866526666190226162225
   PubMed Web of Science ®Google Scholar
• Türkeş, C. (2019c). A potential risk factor for paraoxonase 1: In silico and in‐vitro analysis of the biological activity of proton‐pump inhibitors. Journal of Pharmacy and Pharmacology, 71(10), 1553–1564. doi:10.1111/jphp.13141
   PubMed Web of Science ®Google Scholar
• Türkeş, C., & Beydemir, Ş. (2020). Inhibition of human serum paraoxonase-I with antimycotic drugs: In vitro and in silico studies. Applied Biochemistry and Biotechnology, 190(1), 252–269. doi:10.1007/s12010-019-03073-3
   PubMed Web of Science ®Google Scholar
• Türkeş, C., Arslan, M., Demir, Y., Cocaj, L., Nixha, A. R., & Beydemir, Ş. (2019). Synthesis, biological evaluation and in silico studies of novel N-substituted phthalazine sulfonamide compounds as potent carbonic anhydrase and acetylcholinesterase inhibitors. Bioorganic Chemistry, 89, 103004. doi:10.1016/j.bioorg.2019.103004
   PubMed Web of Science ®Google Scholar
• Türkeş, C., Beydemir, Ş., & Küfrevioğlu, Ö. İ. (2019). In vitro and in silico studies on the toxic effects of antibacterial drugs as human serum paraoxonase 1 inhibitor. ChemistrySelect, 4(33), 9731–9736. doi:10.1002/slct.201902424
   Web of Science ®Google Scholar
• Türkeş, C., Demir, Y., & Beydemir, Ş. (2019). Anti-diabetic properties of calcium channel blockers: Inhibition effects on aldose reductase enzyme activity. Applied Biochemistry and Biotechnology, 189(1), 318–329. doi:10.1007/s12010-019-03009-x
   PubMed Web of Science ®Google Scholar
• Türkeş, C., Söyüt, H., & Beydemir, Ş. (2013). Inhibition effects of gemcitabine hydrochloride, acyclovir, and 5-fluorouracil on human serum paraoxonase-1 (hPON1): in vitro. Open Journal of Biochemistry, 1, 10–15. doi:10.15764/BIOC.2014.01002
   Google Scholar
• Türkeş, C., Söyüt, H., & Beydemir, Ş. (2014). Effect of calcium channel blockers on paraoxonase-1 (PON1) activity and oxidative stress. Pharmacological Reports, 66(1), 74–80. doi:10.1016/j.pharep.2013.08.007
   PubMed Web of Science ®Google Scholar
• Türkeş, C., Söyüt, H., & Beydemir, Ş. (2015). Human serum paraoxonase-1 (hPON1): in vitro inhibition effects of moxifloxacin hydrochloride, levofloxacin hemihidrate, cefepime hydrochloride, cefotaxime sodium and ceftizoxime sodium. Journal of Enzyme Inhibition and Medicinal Chemistry, 30(4), 622–628. doi:10.3109/14756366.2014.959511
   PubMed Web of Science ®Google Scholar
• Türkeş, C., Söyüt, H., & Beydemir, Ş. (2016). In vitro inhibitory effects of palonosetron hydrochloride, bevacizumab and cyclophosphamide on purified paraoxonase-I (hPON1) from human serum. Environmental Toxicology and Pharmacology, 42, 252–257. doi:10.1016/j.etap.2015.11.024
   PubMed Web of Science ®Google Scholar
• Wilbur, K. M., & Anderson, N. G. (1948). Electrometric and colorimetric determination of carbonic anhydrase. The Journal of Biological Chemistry, 176(1), 147–154.
   PubMed Web of Science ®Google Scholar
• Yamali, C., Gul, H. I., Kazaz, C., Levent, S., & Gulcin, I. (2020). Synthesis, Structure Elucidation, and In Vitro Pharmacological Evaluation of Novel Polyfluoro Substituted Pyrazoline Type Sulfonamides as Multi-Target Agents for Inhibition of Acetylcholinesterase and Carbonic Anhydrase I and II Enzymes. Bioorganic Chemistry, 96, 103627. doi:10.1016/j.bioorg.2020.103627
   PubMed Web of Science ®Google Scholar
• Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., Johnson, M. R., Kasper, E. K., Levy, W. C., Masoudi, F. A., McBride, P. E., McMurray, J. J. V., Mitchell, J. E., Peterson, P. N., Riegel, B., … Wilkoff, B. L. (2013). 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 62(16), e147–e239. doi:10.1016/j.jacc.2013.05.019
   PubMed Web of Science ®Google Scholar
• Yoo, M.-G., Park, K. J., Kim, H.-J., Jang, H. B., Lee, H.-J., & Park, S. I. (2019). Association between alcohol intake and incident hypertension in the Korean population. Alcohol, 77, 19–25. doi:10.1016/j.alcohol.2018.09.002
   PubMed Web of Science ®Google Scholar